CROCS, INC.

CROX

CIK 0001334036 · Quarterly mode · latest period FY2026 (Q1) (ending 2026-03-31) · sourced from SEC EDGAR

At a glance · FY2026 (Q1)

Revenue
$921M
↓-1.7% -$16Mvs FY2025 (Q1)
Operating Income
$201M
↓-9.9% -$22Mvs FY2025 (Q1)
Net Income
$138M
↓-14.1% -$23Mvs FY2025 (Q1)
Gross Profit
$523M
↓-3.4% -$19Mvs FY2025 (Q1)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
26/100
  • Profitability
    0ROIC 2.6% (10% = solid, 20%+ = moat)
  • Liquidity
    38Current Ratio 1.27 (above 1.5 = solid)
  • Leverage
    52D/E 0.95 (under 0.5 = conservative)
  • Efficiency
    54Asset Turnover 0.90x (1.0+ = capital-efficient)
  • Growth
    11Revenue YoY -1.7% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Op Margin 21.8% · trend -22.9pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project CROX's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

10%

Trailing 3-yr CAGR was 9.7%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$227.00
Total enterprise IV
$12.31B
Diluted shares
0.05B
Terminal PV
$9.01B (73% of total)
Year-5 FCF
$1.06B
YearProjected FCFDiscounted PV
+1$725M$659M
+2$798M$659M
+3$877M$659M
+4$965M$659M
+5$1.06B$659M
Terminal$14.51B$9.01B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$54M
investment in PP&E
Stock buybacks (TTM)
$521M
share count reduction
Stock-based comp (TTM)
$39M
non-cash dilution

Balance sheet · 2026-03-31

latest filed snapshot
Total assets
$4.34B
everything owned
Total liabilities
$2.92B
everything owed
Stockholders' equity
$1.43B
shareholder claim
Net debt
$1.20B
LT debt minus cash

Recent performance · 64 quarters

Revenue↓-1.7% -$16M
$921M
Net Income↓-14.1% -$23M
$138M
Free Cash Flow↓-19.8% -$16M
$-99M
Operating Margin↓-2.0pts
21.8%

Drill down